Back to RCUS
GILEAD SCIENCES, INC. RCUS Position History
Arcus Biosciences, Inc. • Healthcare
Quarters held
5
Latest value
$811.7M
Q3 2026
Peak value
$968.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $427.4M |
| Q4 2025 | $748.9M |
| Q1 2026 | $678.8M |
| Q2 2026 | $968.8M |
| Q3 2026 | $811.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $811.7M | 31.42M | — | — |
| Q2 2026 | $968.8M | 31.42M | — | — |
| Q1 2026 | $678.8M | 31.42M | — | — |
| Q4 2025 | $748.9M | 31.42M | — | — |
| Q3 2025 | $427.4M | 31.42M | — | — |
Other funds holding RCUS
$318.3M
$275.6M
$226M
$208.7M
$185.9M
$185.9M
$147.3M